Nebula Genomics

Nebula Genomics is a human genome sequencing and health big data company that aims to build a large and trusted genomic and health data marketplace for consumers, researchers and the medical community. Using blockchain to ensure that consumers maintain control of their data and are compensated for its use, the Nebula marketplace will aggregate a critical mass of rich genetic information that researchers can analyze in order to accelerate drug development, streamline clinical trials, and usher in the era of truly personalized medicine. The company was founded in 2017 by Harvard genomics pioneer George Church, along with Harvard researchers Dennis Grishin and Kamal Obbad.